FIBRICOR (Aralez Pharmaceuticals US Inc.)
Welcome to the PulseAid listing for the FIBRICOR drug offered from Aralez Pharmaceuticals US Inc.. This Peroxisome Proliferator Receptor alpha Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Aralez Pharmaceuticals US Inc. |
| NON-PROPRIETARY NAME: | Fenofibric Acid |
| SUBSTANCE NAME: | FENOFIBRIC ACID |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Peroxisome Proliferator Receptor alpha Agonist [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-08-05 |
| END MARKETING DATE: | 0000-00-00 |
FIBRICOR HUMAN PRESCRIPTION DRUG Details:
| Item Description | FIBRICOR from Aralez Pharmaceuticals US Inc. |
| LABELER NAME: | Aralez Pharmaceuticals US Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 35(mg/1) |
| START MARKETING DATE: | 2017-08-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70347-035_8ddb7d22-8beb-4eba-81a5-814cfdecbfae |
| PRODUCT NDC: | 70347-035 |
| APPLICATION NUMBER: | NDA022418 |
Other FENOFIBRIC ACID Pharmaceutical Manufacturers / Labelers:
